Pattern of Compliance and Efficacy of Repetitive Transcranial Magnetic Stimulation Protocol for Treating Major Depressive Disorder Among Treatment Participants and Completers: A Report From Iran

INTRODUCTION: Since the introduction of the Food and Drug Administration (FDA)-approved repetitive transcranial magnetic stimulation (rTMS) intervention in 2008, a breakthrough has been made in treating major depressive disorder (MDD). However, many sessions of treatment and its cost make it inconve...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaghband-rad, Javad, Motamed, Mahtab, Khazaeipour, Zahra, Farhadbeigi, Parvaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Neuroscience Society 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693813/
https://www.ncbi.nlm.nih.gov/pubmed/38050571
http://dx.doi.org/10.32598/bcn.2021.3369.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693813/
https://www.ncbi.nlm.nih.gov/pubmed/38050571
http://dx.doi.org/10.32598/bcn.2021.3369.1

Ejemplares similares